Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07413939 |
| Title | RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive (BREnnA) |
| Acronym | BREnnA |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Hoffmann-La Roche |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Hopital du Saint Sacrement | RECRUITING | Québec | Quebec | G1S 4L8 | Canada | Details |
| Taichung Veterans General Hospital | RECRUITING | Taichung | 407219 | Taiwan | Details | |
| National Cheng Kung University Hospital | RECRUITING | Tainan | 00704 | Taiwan | Details | |
| National Taiwan Uni Hospital | RECRUITING | Taipei | 10041 | Taiwan | Details |